Stock listing

A2H7JK Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: A2H7JK · LS · EUR · DE

The selected listing A2H7JK:LS represents Telix Pharmaceuticals Limited. Telix is a biopharmaceutical company focused on the development of targeted therapies for cancer and other serious diseases. Recent news highlights their advancements in clinical trials and partnerships aimed at enhancing their product pipeline. Investors can stay informed through the latest filings and events that reflect the company's progress in the competitive healthcare market.

A2H7JK:LSEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
A2H7JK:LS
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Telix Pharmaceuticals Limited A2H7JK:LS stock context

The selected listing A2H7JK:LS represents Telix Pharmaceuticals Limited. Telix is a biopharmaceutical company focused on the development of targeted therapies for cancer and other serious diseases. Recent news highlights their advancements in clinical trials and partnerships aimed at enhancing their product pipeline. Investors can stay informed through the latest filings and events that reflect the company's progress in the competitive healthcare market.

Research Telix Pharmaceuticals Limited

Alternate listings